
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds
Ana Martins Barbosa, Fátima Martel
Cancers (2020) Vol. 12, Iss. 1, pp. 154-154
Open Access | Times Cited: 112
Ana Martins Barbosa, Fátima Martel
Cancers (2020) Vol. 12, Iss. 1, pp. 154-154
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2252-2252
Open Access | Times Cited: 158
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2252-2252
Open Access | Times Cited: 158
Glucose Transporters as a Target for Anticancer Therapy
Monika Pliszka, Leszek Szablewski
Cancers (2021) Vol. 13, Iss. 16, pp. 4184-4184
Open Access | Times Cited: 132
Monika Pliszka, Leszek Szablewski
Cancers (2021) Vol. 13, Iss. 16, pp. 4184-4184
Open Access | Times Cited: 132
The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
Chang Liu, Ying Jin, Zhimin Fan
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 132
Chang Liu, Ying Jin, Zhimin Fan
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 132
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 32
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Xingting Bao, Jinhua Zhang, Guomin Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 85
Xingting Bao, Jinhua Zhang, Guomin Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 85
Reactive Glycolysis Metabolite‐Activatable Nanotheranostics for NIR‐II Fluorescence Imaging‐Guided Phototherapy of Cancer
Yi Lai, Yijing Dang, Fenglin Li, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 23
Closed Access | Times Cited: 44
Yi Lai, Yijing Dang, Fenglin Li, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 23
Closed Access | Times Cited: 44
[Retracted] Detection of Breast Cancer Using Histopathological Image Classification Dataset with Deep Learning Techniques
V. K. Reshma, Nancy Arya, Sayed Sayeed Ahmad, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 40
V. K. Reshma, Nancy Arya, Sayed Sayeed Ahmad, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 40
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 33
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 11
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 11
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 8
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 8
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188457-188457
Open Access | Times Cited: 55
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188457-188457
Open Access | Times Cited: 55
Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer
Leila Kooshki, Parisa Mahdavi, Sajad Fakhri, et al.
BioFactors (2021) Vol. 48, Iss. 2, pp. 359-383
Closed Access | Times Cited: 50
Leila Kooshki, Parisa Mahdavi, Sajad Fakhri, et al.
BioFactors (2021) Vol. 48, Iss. 2, pp. 359-383
Closed Access | Times Cited: 50
Akt Isoforms: A Family Affair in Breast Cancer
Alakananda Basu, Christoffer Briggs Lambring
Cancers (2021) Vol. 13, Iss. 14, pp. 3445-3445
Open Access | Times Cited: 46
Alakananda Basu, Christoffer Briggs Lambring
Cancers (2021) Vol. 13, Iss. 14, pp. 3445-3445
Open Access | Times Cited: 46
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Jurnal Reang, Prabodh Chander Sharma, Vijay Kumar Thakur, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1130-1130
Open Access | Times Cited: 43
Jurnal Reang, Prabodh Chander Sharma, Vijay Kumar Thakur, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1130-1130
Open Access | Times Cited: 43
Modular Design of High-Brightness pH-Activatable Near-Infrared BODIPY Probes for Noninvasive Fluorescence Detection of Deep-Seated Early Breast Cancer Bone Metastasis: Remarkable Axial Substituent Effect on Performance
Peng Wu, Yu Zhu, Senyao Liu, et al.
ACS Central Science (2021) Vol. 7, Iss. 12, pp. 2039-2048
Open Access | Times Cited: 41
Peng Wu, Yu Zhu, Senyao Liu, et al.
ACS Central Science (2021) Vol. 7, Iss. 12, pp. 2039-2048
Open Access | Times Cited: 41
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
Lei Pan, Wenzhou Wang, Marisela Sheldon, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3390-3390
Open Access | Times Cited: 19
Lei Pan, Wenzhou Wang, Marisela Sheldon, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3390-3390
Open Access | Times Cited: 19
Betulinic acid in the treatment of breast cancer: Application and mechanism progress
Huijuan Mu, Yuli Sun, Bo Yuan, et al.
Fitoterapia (2023) Vol. 169, pp. 105617-105617
Closed Access | Times Cited: 17
Huijuan Mu, Yuli Sun, Bo Yuan, et al.
Fitoterapia (2023) Vol. 169, pp. 105617-105617
Closed Access | Times Cited: 17
Understanding Breast Cancer Aggressiveness and Its Implications in Diagnosis and Treatment
Nader Afifi, Carlos A. Barrero
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1375-1375
Open Access | Times Cited: 16
Nader Afifi, Carlos A. Barrero
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1375-1375
Open Access | Times Cited: 16
The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment
Ajeesh Babu Littleflower, Sulfath Thottungal Parambil, Gisha Rose Antony, et al.
Biochimie (2024) Vol. 220, pp. 107-121
Closed Access | Times Cited: 7
Ajeesh Babu Littleflower, Sulfath Thottungal Parambil, Gisha Rose Antony, et al.
Biochimie (2024) Vol. 220, pp. 107-121
Closed Access | Times Cited: 7
Comparison between sodium‐glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real‐world evidence study
Hui‐Lin Sung, Chuan‐Yu Hung, Yu‐Chun Tung, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 3
Closed Access | Times Cited: 6
Hui‐Lin Sung, Chuan‐Yu Hung, Yu‐Chun Tung, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 3
Closed Access | Times Cited: 6
Cancer Glycolytic Dependence as a New Target of Olive Leaf Extract
Jessica Ruzzolini, Silvia Peppicelli, Francesca Bianchini, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 317-317
Open Access | Times Cited: 49
Jessica Ruzzolini, Silvia Peppicelli, Francesca Bianchini, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 317-317
Open Access | Times Cited: 49
Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
Adviti Naik, Julie Decock
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 45
Adviti Naik, Julie Decock
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 45
Proteomics and its applications in breast cancer.
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, et al.
PubMed (2021) Vol. 11, Iss. 9, pp. 4006-4049
Closed Access | Times Cited: 34
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, et al.
PubMed (2021) Vol. 11, Iss. 9, pp. 4006-4049
Closed Access | Times Cited: 34
Colloidally Stabilized DSPE-PEG-Glucose/Calcium Phosphate Hybrid Nanocomposites for Enhanced Photodynamic Cancer Therapy via Complementary Mitochondrial Ca2+ Overload and Autophagy Inhibition
Xuan Wang, Yunhao Li, Xiongwei Deng, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 33, pp. 39112-39125
Closed Access | Times Cited: 33
Xuan Wang, Yunhao Li, Xiongwei Deng, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 33, pp. 39112-39125
Closed Access | Times Cited: 33
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
Mithlesh Kumar Temre, Ajay Kumar, Sukh Mahendra Singh
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Mithlesh Kumar Temre, Ajay Kumar, Sukh Mahendra Singh
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24